Conclusion: Circulating adiponectin, irisin, and RBP-4 may be new biomarkers in OSAS patients in addition to risk factors such as diabetes, obesity, and hypertension. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.